Oncology

Clinical Charts

Antiemetic Treatments

Publish Date April 18, 2022

Antiemetic treatment chart including drug formulations, strengths, and usual doses for nausea/vomiting.

Clinical Charts

FDA-Approved Ovarian Cancer Treatments

Publish Date February 23, 2022

FDA-Approved treatment options for individuals with ovarian cancer including dosing.

Clinical Charts

FDA-Approved Non-Small Cell Lung Cancer (NSCLC) Treatments

Publish Date February 23, 2022

Chemotherapeutic and biologic agents for the treatment of non-small cell lung cancer (NSCLC).

Clinical Charts

FDA-Approved Melanoma Treatments

Publish Date February 23, 2022

FDA-approved drug therapies for cutaneous melanoma.

Clinical Charts

FDA-Approved Colorectal Cancer Treatments

Publish Date February 23, 2022

Colorectal cancer treatment regimen chart.

Clinical Charts

FDA-Approved Breast Cancer Treatments

Publish Date February 23, 2022

FDA-approved oral and injectable treatment options for breast cancer.

Clinical Charts

FDA-Approved Prostate Cancer Treatments

Publish Date December 28, 2021

Approved prostate cancer drug treatments including formulations and usual dosing.

Pediatric Cancer

FDA Approves Rituxan Plus Chemotherapy for Certain Pediatric Hematologic Cancers

By

Brian Park, PharmD

Publish Date December 6, 2021

The approval was based on data from the open-label, randomized phase 3 Inter-B-NHL Ritux 2010 trial.

News

Cytalux Approved to Detect Ovarian Cancer Lesions During Surgery

By

Brian Park, PharmD

Publish Date November 30, 2021

Cytalux is a fluorescent drug intended to assist surgeons in identifying ovarian cancer lesions.

Gastrointestinal Cancers

Erbitux Plus Encorafenib Approved for BRAF V600E Mutation-Positive Metastatic Colorectal Cancer

By

Brian Park, PharmD

Publish Date October 1, 2021

The approval is supported by data from the phase 3 BEACON CRC trial.